|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|1394962||1501094||2016||6 صفحه PDF||سفارش دهید||دانلود رایگان|
• From common aldehyde, alkynes and homologated hydroxymethylalkynes were prepared.
• Libraries of triazoles were prepared for comparison between both classes of compounds.
• First results were obtained for cytotoxicities ont CT26 cell line.
• A tentative structure-activity relationship, based on interpretable results was proposed.
In this manuscript we describe synthesis and cytotoxicity evaluation of some triazolic derivatives against B16 melanoma cell line. For this purpose, we transformed a set of aromatic aldehydes into terminal alkynes, using Besthmann-Ohira reagent, and we made the corresponding hydroxymethyl homologated alkynes by an acetylene Grignard reagent. These generated two sets of alkynes were then subjected to a copper(I)-catalyzed alkyne-azide cycloaddition reaction (CuAAC) using a solid-supported catalyst (Amberlyst A-21 CuI), with a third set composed of organic azides. Synthesized triazoles were then tested in vitro against B16 melanoma cell line. Amongst them, compounds a1b1 (R1 = p-nitrophenyl, R2 = benzyl), a4b1 (R1 = naphthyl, R2 = benzyl) and a4b5 (R1 = naphthyl, R2 = (R/S)- dioxolane) showed the best activity against B16 melanoma cells, with IC50 of 5.12, 3.89 and 6.60 μM respectively.
Figure optionsDownload as PowerPoint slide
Journal: European Journal of Medicinal Chemistry - Volume 122, 21 October 2016, Pages 436–441